ABCG2 and malignant colon neoplasm: Furthermore, the aforementioned D3 receptor antagonists significantly reversed ABCG2-mediated MDR in both lung and colon cancer cell lines overexpressing ABCG2 transporters, by inhibiting the efflux function of ABCG2 transporters and down regulating the expression levels of ABCG2 transporters [19].